Effects of Growth Hormone Following Chronic Angiotensin-converting Enzyme Inhibition in Chronic Heart Failure: Their Relation to Infarct Size

被引:0
作者
Minoru Hongo
Eiji Hironaka
Osamu Yokoseki
Noboru Watanabe
Toshishige Shibamoto
Mafumi Owa
Tsutomu Ryoke
机构
[1] Yamaguchi University School of Medicine,First Department of Internal Medicine
[2] Shinshu University School of Medicine,Central Laboratory
[3] Kanagawa Medical University,Department of Physiology
[4] Yamaguchi University School of Medicine,Second Department of Internal Medicine
来源
Cardiovascular Drugs and Therapy | 2001年 / 15卷
关键词
growth hormone; ACE inhibitors; heart failure; myocardial infarction; myocardium; infarct size;
D O I
暂无
中图分类号
学科分类号
摘要
Growth hormone (GH) has been attracted as a possible adjunctive treatment for severe heart failure. However, its treatment effects have been still controversial. To assess severity of basal cardiac disease states in which GH might be effective, we analyzed the relation of treatment effects of GH following chronic angiotensin-converting enzyme (ACE) inhibition on cardiac function and structures to infarct size in rat model of chronic heart failure after myocardial infarction. One day after coronary occlusion, rats were randomized to either an ACE inhibitor, temocapril (T) (80 mg/L in drinking water) or placebo for 12 weeks. The animals received concomitant recombinant human (rh) GH (2 mg/kg/day, SC) (T + GH) or vehicle during the final 2 weeks. Compared with the T group, the T + GH group with large MI had smaller increments of left ventricular (LV) dP/dtmax (0 vs 17%) and cardiac output (9 vs 49%), less improvement of LV relaxation (tau) (−3 vs 29%) and systemic vascular resistance (8 vs 29%), and a greater increase in LV end-diastolic pressure (123 vs −5%) than did the T + GH group with moderate MI. In the T + GH group when compared with the T group, these functional alterations were associated with a 12% reduction in the LV capillary density and a 21% increase in hydroxyproline contents in rats with large MI, whereas a 12% increase in the density and similar collagen contents were found in rats with moderate MI. Thus, prominent beneficial cardiovascular effects of the additive short-term, high-dose GH to chronic high-dose ACE inhibition were obtained in rats with moderate MI, whereas little additional benefit or even detrimental effects of GH were found in rats with large MI. The present study may provide an insight into the therapeutic strategy of GH given late after MI in the presence of chronic ACE inhibition in congestive heart failure.
引用
收藏
页码:241 / 249
页数:8
相关论文
共 117 条
[1]  
Saccá L(1996)Cardiac performance: Growth hormone enters the race Nat Med 2 29-31
[2]  
Fazio S.(1999)Growth hormone, cardiomyocyte contractile reserve, and heart failure Circulation 99 15-17
[3]  
Ross J(1996)A preliminary study of growth hormone in the treatment of dilated cardiomyopathy N Engl J Med 334 809-814
[4]  
Fazio S(1999)Recombinant growth hormone therapy in patients with ischemic cardiomyopathy: Effects on hemodynamics, left ventricular function, and cardiopulmonary exercise capacity Circulation 99 18-21
[5]  
Sabatini D(1996)Exogenously administered growth hormone and insulin-like growth factor-1 alter intracellular Ca2 Circ Res 79 227-236
[6]  
Capaldo B(1999) handling and enhance cardiac performance: In vivo evaluation in the isolated isovolumic buffer-perfused rat heart Circulation 99 127-134
[7]  
Genth-Zotz S(1996)Treatment with growth hormone enhances contractile reserve and intracellular calcium transients in myocytes from rats with postinfarction heart failure J Cardiac Failure 2 S121-S128
[8]  
Zotz R(1998)The role of hypertrophy and growth factors in heart failure Cardiovasc Res 40 64-73
[9]  
Geil S(1999)Growth hormone preserves cardiac sarcoplasmic reticulum Ca2 Circulation 100 2003-2009
[10]  
Voigtl änder T(1998) release channels (ryanodine receptors) and enhances cardiac function in cardiomyopathic hamsters Lancet 351 1233-1237